Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 24 of the 24 references it cites were found in a registry or an index.

Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis

Abstract

OBJECTIVE: We sought to determine the factors associated with survival after recurrence of hepatocellular cancer (HCC) after resection and the outcome of our prospectively applied treatment protocol. BACKGROUND: Very little is known about the prognosis of HCC that recurs after resection and the outcomes associated with treatments applied to recurrent tumors. METHODS: A total of 661 HCC patients undergoing resection from January 1988 to January 2011 were reviewed to identify those with recurrence. Single recurrences with preserved liver function, and no portal hypertension were treated with resection. Patients with multiple intrahepatic tumors or poor liver function and no major comorbidities were listed for transplantation. Patients with up to 3 tumors, each 4 cm or smaller, and not eligible for transplantation, received ablation. Patients not eligible for ablation received embolization. Other treatments such as systemic therapy and radiation were used in remaining patients, but not in a systematic manner. RESULTS: Recurrent HCC developed in 356 (54%) patients at a median time of 22 months from primary resection. Median survival from time of recurrence to death was 21 months. Variables independently associated with survival from recurrence included time from primary resection to recurrence, alpha-fetoprotein more than 100 ng/mL at recurrence, recurrent tumor larger than 3 cm, BCLC stage at recurrence, and type of treatment rendered for the recurrence. All variables except treatment modality were significantly correlated with characteristics of the original primary tumor. CONCLUSIONS: Most of the variables associated with outcome after recurrence are linked to the primary tumor at initial presentation. Nevertheless, meaningful survival can be achieved with appropriate treatment of recurrent tumors.

Overview

Integrity signals

Registry

Crossref · 10.1097/sla.0000000000000710

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 1

  1. Jin, 2014, Transarterial chemoembolization versus surgeryradiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion., J Gastroenterol, 29, 1056

Cited by

See all 904

Metadata

Authors
Tabrizian, P., Jibara, G., Shrager, B., Schwartz, M., & Roayaie, S.
Affiliations
  • Mount Sinai Hospital (US)
  • Brookdale University Hospital and Medical Center (US)
  • Morristown Medical Center (US)
  • Northwell Health (US)
Corresponding author
  • Tabrizian, Parissa
  • Schwartz, Myron
Venue
Annals of Surgery
Published
2015-05
Volume
261
Issue
5
Pages
947-955
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2333367339
Cited by
903
References
24
Citations by year
2026: 73 · 2025: 130 · 2024: 120 · 2023: 137 · 2022: 136 · 2021: 119 · 2020: 84 · 2019: 51 · 2018: 25 · 2017: 16 · 2016: 6 · 2015: 4
FWCI
5.23
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
  • Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
Keywords
hepatocellular carcinoma, tumor recurrence, hepatectomy, survival after recurrence, prognostic factors, alpha-fetoprotein, Barcelona Clinic Liver Cancer staging, liver transplantation, ablation, endovascular embolization, portal hypertension, liver function
MeSH terms
Algorithms, Embolization, Therapeutic, Female, Hepatectomy, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Prognosis, Reoperation, Time Factors, Survival Analysis, Liver Transplantation, Ablation Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis. https://app.cochat.ai/papers/10.1097/sla.0000000000000710
The paper
Tabrizian, P., Jibara, G., Shrager, B., Schwartz, M., & Roayaie, S. (2015). Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis. Annals of Surgery. https://doi.org/10.1097/sla.0000000000000710

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.